Background and Aim: Although the Cancer of the Liver Italian Program (CLIP) score
Japan Integrated Staging (JIS) score and the Tokyo score were established as an integrated prognostic system for HCC patients, combining tumor progression with liver functional reserve. [2] [3] [4] Previous studies have reported that the JIS score seems to be a better predictor for prognosis of patients undergoing liver resection in comparison with the CLIP score and the Tokyo score. 5, 6 Recently, a large population study (n = 3182) showed that the CLIP score is the best prognostic system for HCC in comparison with several prognostic systems including the JIS score and the Tokyo score, because the CLIP score had the highest homogeneity in patients with the same stage. 7 This study showed that the CLIP score attracted attention as the best predictor of HCC patients. However, the CLIP score inadequately estimates outcome after curative resection for HCC, because it includes HCC patients with distant metastasis (3.2%, 14/435), Child-Pugh classification C (15.9%, 69/435), and non-surgical treatment (90.8%, 395/435). 2 Although a previous study has reported that the CLIP score is useful for prognostication of HCC patients receiving non-surgical treatment, 8 it is inferior to other prognostic systems for prognostication of HCC patients undergoing surgery. 5 In our previous study, most HCC patients (74.0%, 222/300) undergoing liver resection had a low CLIP score (0-1). 9 Additionally, because CLIP score was not good at stratifying the postoperative outcome of such patients, CLIP score was inferior to hepatic Glasgow Prognostic Score in prognostication of HCC patients undergoing liver resection. 9 In order to apply the CLIP score to prognostication of HCC patients undergoing curative resection, further investigation is required to stratify the prognosis of those with a low CLIP score.
Recent studies have shown that the lymphocyte-to-monocyte ratio (LMR) is useful for prognostication of patients with various types of cancer. 10, 11 LMR includes lymphocytes and monocytes, which play a crucial role in the immune system. As tumor infiltrating lymphocytes are well known to exert an antitumor effect by inhibiting the proliferation of tumor cell, decreased lymphocyte count might indicate a weak antitumor reaction and poor clinical outcome. 12 In contrast, monocytes are white blood cells that can further differentiate into a range of tissue macrophages and dendritic cells. 13 Monocytes promote tumorigenesis through local immune suppression 14 and, in addition, can differentiate into tumor-associated macrophages (TAM), which promote tumor growth, angiogenesis, invasion, and metastasis. 15 Thus, in cancer patients, peripheral blood lymphopenia and an increased monocyte count are associated with poor prognosis.
In patients with HCC, several studies have reported that the LMR is significantly associated with surgical outcome after curative resection. [16] [17] [18] As a low LMR was associated with tumor size, vascular invasion and tumor staging, it could be a good predictor of post-surgical outcome in HCC patients. [16] [17] [18] Therefore, LMR might be able to stratify the prognosis of HCC patients with a low CLIP score undergoing curative resection. In the present study, we investigated whether the LMR was able to stratify the prognosis of HCC patients with a low CLIP score.
F I G U R E 1 Receiver operating characteristic (ROC) curve shows the optimal cut-off value for the lymphocyteto-monocyte ratio (LMR). Arrow shows the most prominent point on the ROC curve. AUROC curve of the LMR for overall survival is 0.559 Figure 1 ).
| PATIENTS AND ME THODS

| Calculation of LMR
Lymphocyte-to-monocyte ratio was calculated as: LMR = peripheral lymphocyte count (/mm 3 or %)/peripheral monocyte count (/mm 3 or %).
| Diagnosis of liver cirrhosis
Liver cirrhosis was pathologically diagnosed as stage f4 when bridging fibrosis was observed surrounding the regenerative nodules in the liver parenchyma of the resected specimen. 
| Definition of CLIP score
The CLIP score is based on four items and ranges from 0 to 6.
These four items include Child-Pugh classification (A = 0, B = 1, or when the levels of tumor markers were above the normal range.
However, if 5 years had passed since surgery, CT interval was prolonged from 6 to 12 months, or CT was carried out when the levels of tumor markers were above the normal range.
| Statistical analysis
All statistical analyses were carried out using SPSS software (version Table 2 . There were no significant differences between the two LMR groups in all categorical clinical characteristics.
| RE SULTS
Continuous clinicolaboratory characteristics of patients in the two
LMR group are listed in Table 3 . There were significant differences between the two LMR groups in the serum levels of albumin, ALT and CRP. were closely associated with poor OS (Table 4) .
Results of univariate analyses showed that AFP (>20/≤20, ng/ 95% CI, 95% confidence interval; AFP, alpha-fetoprotein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CLIP, Cancer of the Liver Italian Program; CRP, C-reactive protein; HBsAg, hepatitis B surface antigen; HCVAb, hepatitis C virus antibody; HR, hazard ratio; ICGR15, indocyanine green retention rate at 15 min; LMR, lymphocyte-to-monocyte ratio; PIVKA-II, protein induced by vitamin K antagonist II; PT, prothrombin time; TNM, tumor-node-metastasis; WBC, white blood cell. surgery (P < 0.001) (Figure 4) . Results of chi-squared test showed that LMR was not significantly associated with recurrence pattern (intrahepatic/extrahepatic) and salvage surgery (yes/no) ( Table 6 ).
| D ISCUSS I ON
It has been reported previously that most patients who undergo curative liver resection for HCC have a low CLIP score (0-1) (73.4%, 433/599) 6 . In order to apply the CLIP score to prognostication after curative surgery for HCC, a score of 0 or 1 must stratify postoperative outcome. However, because the CLIP score is unable to stratify the postoperative outcome of HCC patients with a low score (0-1), 5 its performance for prognostication after curative surgery for HCC is poor. Our study showed that the LMR (<4.35/≥4.35) significantly stratified the outcome after curative surgery for HCC patients with a low CLIP score, thus resolving this problem associated with the CLIP score.
F I G U R E 2
Relationship between the lymphocyte-to-monocyte ratio (LMR) and overall survival after curative resection for hepatocellular carcinoma patients with a Cancer of the Liver Italian Program (CLIP) score of 0 or 1
Relationship between the lymphocyte-to-monocyte ratio (LMR) and relapse-free survival after curative resection for hepatocellular carcinoma patients with a Cancer of the Liver Italian Program (CLIP) score of 0 or 1
Although previous studies have shown that a low LMR is associated with tumor progression, [16] [17] [18] we found that a low LMR (<4.35) was not associated with tumor-related characteristics such as vascular invasion, TNM stage, tumor markers and tumor size.
However, both OS and RFS in the low-LMR group were significantly poorer than those in the high-LMR group, as has been shown previously. [16] [17] [18] Because cancer is the main cause of death in HCC patients, and RFS in the low-LMR group was poorer than that in the high-LMR group, the poor OS in the low-LMR group might have been as a result of recurrence of HCC, which was more frequent than in the high-LMR group.
However, because HCC recurrence can be divided into two types-intrahepatic metastasis (IM) and multicentric occurrence (MO), 24 -it is unclear whether HCC recurrence is one type or the other. IM is defined as intrahepatic recurrence from the original HCC.
However, MO occurrence is defined as new intrahepatic occurrence of HCC. A previous study has reported that positivity for HCVAb, a preoperative low platelet count and large tumor size were useful for the diagnosis of HCC recurrence as a result of IM. 25 Because LMR was not associated with HCVAb, platelet count or tumor size, our result indicated that LMR might be related to MO. In addition, early recurrence of HCC arises mainly from IM and late recurrence is more likely to be caused by MO in origin. 26 Previous study has reported that a recurrence-free time of 3 years after surgery was a significant cut-off time for distinguishing between IM and MO. 27 RFS curve in the present study indicated that early recurrence of patients with low LMR (<4.35) was higher than that with high LMR (≥4.35). This fact indicated that the proportion of patients with IM recurrence might be strongly associated with a low-LMR group as compared to a high-LMR group, because the RFS rate of a low-LMR group decreased more rapidly in the early phase than that of a high-LMR group. In view of the retrospective nature of our study, however, it was unclear whether HCC recurrence had been IM or MO recurrence. Further study will be necessary to determine whether low LMR is associated with HCC recurrence as a result of MO recurrence.
Hepatitis viral infection and liver cirrhosis are both import- nutritional status of cancer patients. 30 In fact, in cancer patients, malnutrition is significantly correlated with a low lymphocyte count, and this can have an adverse impact on prognosis. Because our study showed that patients with a low LMR had poorer nutritional status than those with a high LMR, nutritional intervention might improve the prognosis of such patients. 30, 31 In fact, a previous study has shown that nutritional therapy can improve the outcome after surgery for HCC. 32 Therefore, further studies of the relationship between LMR and nutrition in HCC patients are warranted.
The LMR can significantly stratify postoperative outcome in HCC patients with a low CLIP score undergoing curative resection, and combination of the LMR with the CLIP score was able to predict the postoperative outcome after curative resection for HCC.
Although postoperative intervention is needed for patients with a low LMR to prevent HCC recurrence, there is no effective postoperative adjuvant chemotherapy for such patients. A recent study showed that sorafenib is not an effective intervention in the adjuvant setting for HCC patients following resection or ablation. 33 Among other postoperative adjuvant therapies for HCC patients, immunotherapy, interferon therapy and internal radiation therapy have been reported. [34] [35] [36] A meta-analysis has concluded that interferon therapy is effective for prevention of HCC recurrence after surgery. 37 However, patients rarely receive interferon therapy be- Takayuki Shiraki https://orcid.org/0000-0003-2935-6708
